drugset / Trial / NCT01478256
Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis
RandomizedParallel-groupOpen-labelTreatment
Summary
This study looks at the improvements in signs and symptoms in patients with inflammation of the lids, blepharitis, using two different FDA approved topical antibiotic agents, Besifloxocin and Erythromycin. It also evaluates the bacterial cultures in these patients for microbiologic evidence of improvement.
Timeline
- Start
- 2011-08
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Besifloxacin | Small molecule | 0.6 % | Topical |
| Comparator | Erythromycin | Small molecule | 0.5 % | Topical |